Early-Onset Sensorineural Hearing Loss in a Child with Turner Syndrome

Abstract

Turner syndrome is among the more common but less familiar syndromes that include sensorineural hearing loss and middle ear disease. This article provides a review of the syndrome, an illustrative case, and a review of specific issues relevant to audiologic management of patients with Turner syndrome.

Abbreviations: GH = growth hormone, TS = Turner syndrome

Key Words

Conductive hearing loss - sensorineural hearing loss - Turner syndrome

Publikationsverlauf

Artikel online veröffentlicht:
13. April 2022

• REFERENCES

• Anderson Η, Filipsson R, Fluur Ε, Koch Β, Lindsten J, Wedenberg E. (1969). Hearing impairment in Turner's Syndrome. Acta Otol Laryngol Suppl (Stockh) 247:1–26.
• Ayer-leLievre C, Stahlbom, Sara VR. (1991). Expression of IGF-I and -II mRNAin the brain and craniofacial region of the rat fetus. Development 111:105–115.
• Barreca A. (1997). Insulin-like growth factors (IG-I and IGF-II) and IGF-binding protein-3 produced by fibroblasts of patients with Turner's syndrome in culture. J Clin Endocrinol Metab 82:1041–1046.
• Bondy CA. (1991). Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci 11:3442–3455.
• Buchanan LH. (1990). Early onset of presbycusis in Down syndrome. Scand Audiol 119:103–110.
• Coleman J, Campbell D, Cooper W, Welsh M, Moyer J. (1994). Auditory brainstem responses after ovariectomy and estrogen replacement in rat. Hear Res 80:209–215.
• Donaldson MD. (1997). Growth hormone therapy in Turner syndrome—current uncertainties and future strategies [review]. Horm Res 48 (Suppl 5):35–44.
• Gungor N, Böke Β, Belgin E, Tuncbilek E. (1999). High frequency hearing loss in Turner syndrome. Eur J Pediatr (in press):
• Haubrich J. (1975). Animal experiment historological-histochemical studies on the development of hearing disorders related to hypothyroidism. Acta Otol Laryngol Suppl (Stockh) 332:1–56.
• Holmes C, Thompson R, Hayford J. (1984). Factors related to grade retention in children with short stature. Child Care Health Dev 10:199–210.
• Huisman J, Slijper FM, Sinnema G, Akkerhuis GW, Brugman Boezeman A, Feenstra J, et al. (1993). Psychosocial effects of two years of human growth hormone treatment in Turner syndrome. The Dutch Working Group: Psychologists and Growth Hormone. Horm Res 39(Suppl 2):56–59.
• Hultcrantz M, Li H. (1993). Inner ear morphology in relation to noise, age, and genotype in mice: the CBA/Ca and C57BL. Arch Otorhinolaryngol 250:2157–2164.
• Hultcrantz M, Sylvén L. (1997). Turner's syndrome and hearing disorders in women aged 16–34. Hear Res 103: 69–74.
• Hultcrantz M, Sylvén L, Borg E. (1994). Ear and hearing problems in 44 middle-aged women with Turner's syndrome. Hear Res 76:127–132.
• Laugel G, Wright J, Dengerink H. (1988). Angiotensin II and progesterone effects on laser Doppler measures of cochlear blood flow. Acta Otol Laryngol (Stockh) 106:34–39.
• Leon Y, Vasquez E, Sanz C, Vega J, Mato J, Giraldez F, Represa J, Varela-Nieto I. (1995). Insulin-like growth factor regulates cell proliferation in the developing inner ear, activating glycosyl-phosphatidylinositol hydrolysis and Fos expression. Endocrinology 136:3494–3503.
• Lippe BM. (1996). Turner syndrome. In: Sperling MA, ed. Pediatric Endocrinology. 1st Ed. WB Saunders, 387–421.
• Nielsen J, Wohlert M. (1991). Chromosome abnormalities found among 34,910 newborn children: results from a 13–year incidence study in Arhus, Denmark. Hum Genet 87:81–83.
• Ogata T, Matsuo N. (1995). Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features [review]. Hum Genet 95:607–629.
• Represa J, Avila M, Miner C, Giraldez F, Romero G, Clemente R, Mato J, Varela-Nieto I. (1991). Glycosylphosphatidylinositol/inositol phosphoglycan: a signaling system for the low-affinity nerve growth factor receptor. Proc Natl Acad Sci USA 88:806–809.
• Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, et al. (1998). Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 132:319–324.
• Rovet JF. (1993). The psychoeducational characteristics of children with Turner syndrome. J Learn Disabil 26:333–341.
• Saenger P. (1996). Turner's syndrome. Ν Engl J Med 335:1749–1754.
• Sas TC, de Muinck Κ, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, et al. (1999). Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone. Arch Dis Child 80:36–41.
• Sculateri N, Medina-Ledesma J, Finegold D, Stool S. (1990). Otitis media and hearing loss in Turner syndrome. Arch Otolaryngol Head Neck Surg 116:704–707.
• Sculerati N, Perle Μ, Oddoux C, Clayton M, Ostrer H. (1997). X-inactivation and cytogenetic studies in a family with sensorineural hearing loss and Turner syndrome. Otolaryngol Head Neck Surg 117:S221–S225.
• Stenberg A, Nylén O, Windh M, Hultcrantz M. (1998). Otological problems in children with Turner's syndrome. Hear Res 124:85–90.
• Szpunar J, Rybak M. (1968). Middle ear disease in Turner's syndrome. Arch Otolaryngol 87:52–58.
• Varela-Nieto I, Represa J, Avila M, Miner C, Mato J, Giraldez F. (1991). Inositol phospho-oligosaccharide stimulates cell proliferation in the early developing inner ear. Dev Biol 143:432–435.
• Walzer S, Stanley. (1985). X-chromosome abnormalities and cognitive development: implications for understanding normal human development. J Child Psychol Psychiatry 26:177–184.
• Watkin P. (1989). Otological disease in Turner's syndrome. J Laryngol Otol 731–738.
• Williams J, Richman L, Yarbrough D. (1991). A comparison of memory and attention in Turner syndrome and learning disability. J Pediatr Psychol 16:585–593.